Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Raw Materials (2018 - 2023)

SANUWAVE Health has reported Raw Materials over the past 6 years, most recently at $2.9 million for Q4 2023.

  • Quarterly Raw Materials rose 349.61% to $2.9 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $2.9 million through Dec 2023, up 349.61% year-over-year, with the annual reading at $2.9 million for FY2023, 349.61% up from the prior year.
  • Raw Materials was $2.9 million for Q4 2023 at SANUWAVE Health, up from $641000.0 in the prior quarter.
  • Over five years, Raw Materials peaked at $2.9 million in Q4 2023 and troughed at $185690.0 in Q4 2019.
  • The 5-year median for Raw Materials is $665000.0 (2021), against an average of $894062.7.
  • Year-over-year, Raw Materials soared 874.74% in 2020 and then plummeted 54.3% in 2021.
  • A 5-year view of Raw Materials shows it stood at $185690.0 in 2019, then soared by 874.74% to $1.8 million in 2020, then tumbled by 48.56% to $931000.0 in 2021, then tumbled by 31.15% to $641000.0 in 2022, then skyrocketed by 349.61% to $2.9 million in 2023.
  • Per Business Quant, the three most recent readings for SNWV's Raw Materials are $2.9 million (Q4 2023), $641000.0 (Q4 2022), and $931000.0 (Q4 2021).